ThyCARE (Thyroid and Thyroid CAncer REsearch)
Addressing thyroid health and improving the care of patients across the thyroid cancer continuum
ThyCARE Team picnic, May 2023
1) Thyroid health services research. The health services research team led by Dr. Haymart focuses on research topics related to the diagnosis, prognosis, management, and survivorship of thyroid diseases and thyroid cancer. Our multidisciplinary team is devoted to conducting research studies that directly impact patient care, by examining healthcare delivery, healthcare outcomes and disparities, with the goal of achieving health equity for all patients with thyroid disease and cancer. The team has extensive experience with large national cancer registries, population based studies, survey studies, and most recently behavioral interventions. Our ultimate goal is to improve clinical outcomes, reduce patient harm, and work towards eliminating healthcare disparities in thyroid care.
2) Thyroid cancer clinical trials. For more than fifteen years, Dr. Worden has led the thyroid cancer clinical trials team at the University of Michigan. Clinical trials offer potential benefits to patients with advanced thyroid cancer. It is important for patients with advanced thyroid cancer to have treatment options readily available and to have a team of caregivers who are trained to manage these complex patients. Only through trials with novel therapeutics can we improve survival.
Collaborators include:
endocrinologists
oncologists
surgeons
geriatricians
primary care physicians
biostatisticians
health economists
epidemiologists
survey methodologists
Topics that can be addressed with our team's research:
The rise in thyroid cancer incidence and its implications
Quality of care
Decreasing low-value care
Variation in management
The role of physicians, patients, and caregivers in treatment decisions
Communication between physicians and patients
Thyroid cancer outcomes
Thyroid and aging
Thyroid conditions in vulnerable patient groups
Disparities in thyroid care
Use of imaging in thyroid cancer
Interventions to improve care
Resource utilization
Trial eligibility and enrollment
Novel agents to treat advanced thyroid cancer
Survivorship
Questions or Comments? Please contact Brittany Gay